Pharma Supplier Hub

SomaLogic provides high-plex, high-throughput proteomics using its SomaScan Platform and SOMAmer reagents, measuring up to roughly 11,000 proteins from small-volume samples for research and healthcare. Through CLIA-certified, CAP-accredited fee-for-service assay labs and a global network of authorized sites, the company supports biomarker discovery, translational research, and multiomics initiatives now aligned with Illumina’s genomics ecosystem.

SomaLogic is a proteomics company, now part of Illumina, that provides high‑plex, high‑throughput protein measurement technologies and services. Its SomaScan platform and SOMAmer reagents enable up to 11,000 protein measurements from small samples, supported by CLIA‑certified assay services, global authorized sites, and data analysis tools for biomarker discovery and diagnostics development.

SonALAsense is a clinical-stage biopharmaceutical company pioneering SONALA-001 sonodynamic therapy (SDT), a first-in-class noninvasive drug–device combination for targeted cancer cell death in brain tumors and other cancers. With early clinical proof-of-concept, FDA-cleared trials in high-grade gliomas and DIPG, and significant ARPA-H funding for blood cancer applications, the company is positioning SDT as a scalable oncology platform technology.

Sonoma Biotherapeutics is a private, clinical-stage biotech company headquartered in South San Francisco and Seattle, focused on engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases. Its lead autologous CAR‑Treg candidate, SBT-77-7101, is in Phase 1 trials for rheumatoid arthritis and hidradenitis suppurativa, supported by proprietary Treg engineering and manufacturing platforms grounded in Nobel-recognized Treg biology.

ProteoNic is a Leiden-based biotech company founded in 2006, specializing in vector and transposon technologies for enhanced recombinant protein production. Its 2G UNic platform delivers 2-5x higher yields in CHO/HEK systems, with additional offerings for gene therapy viral vectors and glycoengineering.

NanoString’s Bruker Spatial Biology portfolio provides integrated bulk and spatial multiomics platforms, including nCounter, GeoMx DSP, CosMx SMI, CellScape XR, and PaintScape Spatial 3D Genome+. These systems enable high‑plex RNA, protein, and 3D genome analysis in FFPE and fresh‑frozen tissue to support discovery and translational research in oncology, immunology, neuroscience, and biomarker development.

Spear Bio develops ultrasensitive SPEAR immunoassay technology for single-molecule protein biomarker detection in minimal sample volumes. The ISO 13485:2016 certified company serves pharmaceutical R&D and diagnostics markets with assays for neurodegenerative disease biomarkers including pTau 217, GFAP, and Nf-L.

Sphere Bio, a Fluidic Sciences brand, provides picodroplet‑based instruments, consumables, and reagents for high‑throughput single‑cell analysis, isolation, and monoclonality assurance. Its Cyto‑Mine and Cyto‑Mine Chroma platforms support biologics discovery, cell line development, cell therapy, and synthetic biology by enabling multiplex single‑cell screening, viable dispensing, and rapid, documented monoclonality within integrated automated workflows.

SphingoTec GmbH is a private diagnostics company in Hennigsdorf near Berlin that develops novel blood-based protein biomarkers for acute and critical care, such as acute kidney injury, sepsis, and acute heart failure. It commercializes assays like sphingotest® penKid® and bio‑ADM® as microtiter plate and ELISA tests, and out-licenses its proprietary biomarkers to IVD and pharma partners for clinical diagnostics and critical care drug development.

Porvair Sciences Limited is the Laboratory Division company of Porvair plc, specialising in microplates, porous plastics and microplate handling instruments for life science and analytical laboratories. From high-quality plates and seals to evaporators, robotic-compatible equipment, custom manufacturing and OEM services, it supports high-throughput, reproducible sample preparation and analysis for pharma, biotech and diagnostic customers.

Standard BioTools Inc. is a public life science tools company providing leading proteomic, genomic and multi‑omic solutions, including CyTOF, Hyperion and Biomark platforms. Their research‑use‑only instruments, assays and lab services support high‑parameter immune profiling, spatial biology and high‑throughput genomics for biomarker discovery, drug development and clinical research applications across global pharma, biotech and academic markets.

STARLIMS provides integrated lab informatics solutions – including LIMS, ELN, LES, SDMS and analytics – to optimize workflows, sample management and data integrity across modern laboratories. Its web‑based, enterprise‑ready platforms support compliance, multi‑site collaboration and consolidated reporting for pharma and biotech R&D and QC labs.

Stellaromics is a private life-science technology company focused on True 3D™ spatial multi‑omics with its Pyxa® platform. Pyxa integrates sample prep, volumetric confocal imaging, and analytics to profile transcripts, active translation, and proteins in thick, intact tissue sections, supporting advanced neuroscience, oncology, and translational research via instruments and services.

Journey.io is a SaaS platform that replaces email attachments and scattered links with one branded, trackable page for buyers. It is designed to help sales and procurement teams organize pitch materials, case studies, pricing, and supporting docs in a clearer buying experience.

SureClinical is a private Reno-based eClinical software company offering cloud applications, clinical network functionality, and compliance-validated workflows for clinical operations. Its portfolio includes SureNetwork and SureLearn, with emphasis on automation, collaboration, training, and regulated clinical trial use.

Syndex Bio is a Cambridge, UK–based biotech company developing mcPCR, a proprietary methyl-copying PCR platform that preserves DNA methylation during amplification for high-sensitivity diagnostics. The patented, non-destructive, high-throughput workflow integrates into genomic and multi-omic analyses for oncology, early cancer detection, residual disease monitoring, and patient stratification from low-input clinical samples.

Synthace Ltd is a London-based private life sciences software company that provides a digital experiment platform for discovery biology. It helps pharma and biotech teams design, automate, run, and analyze high-dimensional experiments, with a focus on AI-ready, contextualized data.

Synthego is a CRISPR and molecular diagnostics solutions provider offering guide RNAs, engineered nucleases, base editors and molecular biology reagents for research and clinical workflows. With GMP manufacturing, IND submission support and global distribution, it serves pharma, biotech and diagnostic developers building cell and gene therapies and advanced infectious disease assays.

bit.bio is a synthetic biology company supplying deterministically programmed human iPSC‑derived cells for research, drug discovery and cell therapy. Through its opti‑ox platform and ioCells portfolio, the company delivers scalable, defined human cell types and disease models, supported by technical resources and dedicated order support for pharma, biotech and academic buyers.

TATAA Biocenter is a GLP-accredited molecular bioanalytical CRO specializing in PCR, NGS and proteomics for advanced therapies. It delivers compliant bioanalysis and biomarker assay services for gene therapies, RNA therapeutics and other modalities, backed by proprietary short RNA quantification technologies and extensive regulatory-aligned assay development expertise.

Takara Bio is a global biotechnology group that provides life science reagents, instruments, and CDMO services supporting gene, cell, and regenerative medicine research and development. Headquartered in Japan with major operations in San Jose, California, it enables pharma, biotech, and academic customers to advance biologics, cell and gene therapy, and other advanced modalities from discovery through process development and manufacturing.

Tecan Group Ltd. is a Swiss-based global leader in laboratory automation, diagnostics and OEM instrument development, supplying liquid handling platforms, microplate readers, MS sample prep solutions, immunoassays, consumables and MedTech/diagnostic contract manufacturing services. It serves life sciences, clinical diagnostics and applied markets worldwide, helping pharma and biotech customers scale research and clinical workflows with integrated automation, reagents, software and regulatory expertise.

Telesis Bio is a San Diego–based synthetic biology company providing automated DNA and mRNA synthesis platforms that let researchers build high-fidelity constructs in their own labs. Its BioXp® workstation and Gibson SOLA® platform shorten timelines for antibody discovery, cell and gene therapy, and vaccine development by replacing traditional outsourcing with secure, high-throughput, on-demand workflows.

Tend Dental is a private, U.S.-based network of modern, judgment-free dental studios offering general, family, cosmetic, and orthodontic care. With dozens of locations across New York City, Washington DC, Boston, Atlanta, Westport, and Nashville, Tend combines advanced technology, soothing studio design, online booking, extended hours, and flexible financing to make high-quality dental care convenient for busy individuals and families.